PAI

Palo Alto Investors Portfolio holdings

AUM $470M
This Quarter Return
+2.91%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.76B
AUM Growth
+$1.76B
Cap. Flow
-$48.3M
Cap. Flow %
-2.75%
Top 10 Hldgs %
72.57%
Holding
43
New
2
Increased
20
Reduced
8
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SNDX icon
26
Syndax Pharmaceuticals
SNDX
$1.41B
$5.91M 0.34% 264,200
DNTH icon
27
Dianthus Therapeutics
DNTH
$759M
$5.12M 0.29% 432,300 +5,192 +1% +$61.5K
ZGNX
28
DELISTED
Zogenix, Inc.
ZGNX
$4.19M 0.24% 214,700
TVTX icon
29
Travere Therapeutics
TVTX
$1.56B
$4.15M 0.24% 166,069 +8,169 +5% +$204K
KZR icon
30
Kezar Life Sciences
KZR
$28.9M
$3.91M 0.22% 656,200 +107,994 +20% +$644K
CYTK icon
31
Cytokinetics
CYTK
$4.23B
$2.88M 0.16% 123,686
RIGL icon
32
Rigel Pharmaceuticals
RIGL
$697M
$2.23M 0.13% 652,395 -345,761 -35% -$1.18M
ALIM
33
DELISTED
Alimera Sciences, Inc.
ALIM
$1.93M 0.11% 200,919
ALDX icon
34
Aldeyra Therapeutics
ALDX
$351M
$1.91M 0.11% 160,800
TCMD icon
35
Tactile Systems Technology
TCMD
$297M
$1.48M 0.08% 27,100
ATNX
36
DELISTED
Athenex, Inc. Common Stock
ATNX
$1.37M 0.08% 318,200
SYRS
37
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$603K 0.03% +80,600 New +$603K
MRNS
38
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$485K 0.03% 31,330
URGN icon
39
UroGen Pharma
URGN
$900M
$477K 0.03% 24,500
VIRX
40
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$307K 0.02% 33,212 -83,034 -71% -$768K
NERV icon
41
Minerva Neurosciences
NERV
$16.5M
$106K 0.01% 36,319
ACGN
42
DELISTED
Aceragen, Inc. Common Stock
ACGN
$100K 0.01% 77,044
APRE icon
43
Aprea Therapeutics
APRE
$9.12M
-128,770 Closed -$634K